Steve Bannon turns himself in to New York prosecutors

*Update: According to MSNBC, Bannon has surrendered.

The state of New York is expected to indict Steve Bannon today for the state crime that mirrors the federal crime he was convicted of, only to be ultimately pardoned by Trump. Reading through the Washington Post story that summarizes the details, it’s worth focusing on the fact that New York wouldn’t have to devote the time and resources to prosecuting this case if Trump didn’t love his to pardon friends. It is significant that Trump openly and without apology used the only true dictatorial power he possessed to reward those who favored him. Now New York must work to get justice on this matter:

Stephen K. Bannon is expected to appear before prosecutors Thursday morning to face a state-level criminal indictment, less than two months after he was convicted of contempt of Congress and nearly two years after former President Donald Trump indicted him in a federal proceeding involving fraud contributors to a $25 million fundraiser.

Details of the charges before a state court have not yet been released, but people familiar with the matter say the allegations of fraud were the subject of Bannon’s pardon.

In that case, he was charged in US District Court in Manhattan with personally pocketing $1 million from We Build the Wall, a Trump-sponsored fundraiser that Bannon helped organize beginning in December 2018.

The fact that Bannon and his friends were able to raise money from private individuals who believed they would build the wall themselves is just mind boggling. How gullible (and hateful) do you have to be to send money to a cause without thinking, “Didn’t I vote for a guy who would do this to the government? Shouldn’t Mexico pull out its credit card? Why am I being asked to pay for this personally?”

But this is less about MAGA’s constant willingness to be gifted and more about Bannon’s audacity in committing the scam. This was not an affair involving a complex accounting system with money flowing through three contractors, several cement and steel suppliers and then a Cypriot bank… No. It only came out of the funds as payment of Bannon’s personal dues. That was so bad again. It shows once again that the MAGA movement is nothing more than a gigantic money-moving machine, one fueled by resentment and hatred that you can pull out and shoot for free.

The case is interesting because Trump has raised millions with his “Stop the Steal” campaign, and evidence shows that very little to no money has gone towards any type of effort. The two handles appear to share the same frame. The only real difference might be that Trump has a lot more experience with grifting, and there might be fine print on the “stop the steal” requests that would protect Trump from prosecution.

Regardless, Bannon will go through some things, and this time he doesn’t have an ally who’s willing to forgive him.

@JasonMiciak believes a day without learning is a day not lived. He is a political writer, columnist, author and lawyer. He is a Canadian-born dual citizen who spent his teens and college days in the Pacific Northwest and has since lived in seven states. Today he enjoys life as a single father to a young girl and writes on the beaches of the Gulf Coast. He loves making his flower pots, cooking and is currently studying philosophy of science, religion and non-mathematical principles behind quantum mechanics and cosmology. Please do not hesitate to contact us for lectures or other concerns.

Here is what the Fed rate of interest hike means for Principal Avenue

The U.S. Federal Reserve increased its benchmark interest rate by 75 basis points to a range of 1.5%-1.75% in June — the biggest increase since 1994. Fed Chair Jerome Powell (above) flagged there could be another rate hike in July.

Mary F. Calvert | Reuters

The Federal Reserve raised its benchmark interest rates by 75 basis points on Wednesday, the latest in a series of rate hikes intended to cool the economy and bring down inflation. For all Americans, higher interest rates carry weighty financial implications. Main Street business owners are no exception, as the higher interest rates will flow through to the cost of business loans from lenders including national, regional and community banks, as well as the Small Business Administration’s key 7(a) loan program.

Even more significant may be how the economic slowdown being engineered by the Fed influences consumer demand and the growth outlook for Main Street. With the odds of recession mounting as a result, at least partially, of the recent series of Fed rate hikes, the cost to be paid by Main Street isn’t limited to a bigger monthly debt interest payment and higher cost on new loans. The biggest issue is a business lending market that may quickly dry up as banks pull back on loans to conserve capital and limit risk, and an increasingly smaller percentage of business owners meet stricter credit requirements.

The Federal Reserve is likely not done yet with its rate hikes after the Wednesday decision, with additional increases expected again in September and later in 2022. Here is what small business lending experts say entrepreneurs should be thinking about as they face both higher lending costs and the risk of a slower-growing economy.

1. Borrowing costs will be higher, but still coming off historic lows

Interest rates for business loans, at one point last year, dipped below 4%. That didn’t last, and the average small business loan is on its way to as high as 8%, but it is important to remember that borrowing costs remain very low relative to history. Another 75 basis points from the Fed is not insignificant, and it will flow through the bank lending market.

“When the Fed starts hiking it has a ripple effect across all interest rate indices,” said Chris Hurn, the founder and CEO of Fountainhead, which specializes in small business lending.

But Hurn noted that with the historically low rates, the monthly interest payments made by business owners shouldn’t be impacted as much as the headlines might otherwise suggest. A small business owner taking on debt for a $200,000 piece of equipment, for example, will pay a little extra a month — more or less depending on the loan amortization period — but for most loans the increase in monthly interest should not be a major cash flow issue.

“A few hundred basis points, people can withstand,” Hurn said.

“Most business owners look at that monthly amount and they can support that 75 basis points,” said Rohit Arora, co-founder and CEO of Biz2Credit, which focuses on small business lending. “It’s not that significant on a 10-year loan,” he added.

2. Bank lending requirements are tightening and that process will accelerate

The biggest way that the higher rates may hurt small business is in the overall economic and market effect.

The Fed needs to cool the economy to bring inflation down. In some ways, that should help small businesses manage costs, including labor and inventory.

“Ultimately, business owners understand it’s the greater good,” Hurn said. “They can’t keep raising wages for employees and have higher inventory costs, and pass them along to customers. The Fed has to do something … and if it is a little more expensive … I do believe it will be for a relatively short period. … I think they can hold their nose and swallow hard and accept it as a condition of tamping down inflation,” he said.

In fact, Wall Street expects the Fed to begin cutting rates again as soon as March 2023 based on expectations for a much weaker economy. But that economic outlook will be the big driver of borrowing trends.

“Banks get worried, and the number of people eligible for loans goes down,” Hurn said.

He has seen this play out multiple times in his over two decades as a lender, as banks and credit unions get increasingly tighter when it comes to making business loans as uncertainty in the economy increases. Banks effectively “go to the sidelines,” he said.

While recent data shows business loan approval rates basically unchanged month over month, the credit policies at banks, from community banks to regional and national banks, are already tightening as the economy moves closer to a recession.

“That is occurring and it will accelerate,” Hurn said.

Banks and financial institutions are in a much better position now than they were in 2008.

“More will be weathering the storm, but will pull back on financing expansion,” he said.

Business owners should expect to see the debt service coverage ratios — the operating income available to service all debt principal and interest — increase from what has recently been as low as 1.25 to as high as 1.5.

Many business “won’t be able to hit those numbers,” Hurn said. “And that is what always occurs when we are in a cycle like this.”

Arora said more restrictive debt terms, known as covenants, are starting to be put back into deals, and as the economy pulls back, business owners should expect to see more of this from banks over the remainder of the year and into 2023.

3. SBA 7(a) loans will get more attention, variable rates are a factor

The fact that banks will be stricter on loans doesn’t mean the need for growth capital is declining.

Small business lending demand has been down for a good reason, with many business owners already helped by the Paycheck Protection Program and SBA Economic Injury Disaster Loan program. But demand has been increasing just as rates started going up, in a similar fashion to consumers running through their pandemic stimulus savings yet also running into tighter lending conditions.

Loans made through the SBA 7(a) loan program tend to be slightly more expensive than average bank loans, but that difference will be outweighed by the availability of debt as banks slow their lending. Currently, bank loans are in the range of 6% to 8% while the SBA loans run a little higher, in the range of 7% to 9%.

When the banks aren’t lending, the SBA loan program will see more activity, which SBA lenders Fountainhead and Biz2Credit say is already happening.

“We’re already seeing the shift in volume,” Arora said. “Our volume has been going up over the past three to four weeks,” he added.

Most small business loans made through the Small Business Administration 7(a) loan program are variable, meaning the interest rate resets every 90 days in response to movement in the prime rate, and the total interest rate is a combination of the prime rate plus a maximum 2.75% additional SBA rate. Federal Reserve rate hikes send the prime rate higher, and that in turn means the monthly interest payments on existing debt through the 7(a) program will soon be higher. The price of any new loans will be based on the new prime rate as well.

Approximately 90% of SBA 7(a) loans are variable, prime rate plus the SBA spread, and of those loan types, 90% or more adjust on a quarterly basis as the prime rate adjusts.

While much of the expected interest rate increases are already priced into bank loans, the SBA loan lag means as individual business owners come up on a 90-day rolling window for an interest rate reset, they should expect a higher monthly payment. But that’s common in the world of SBA loans and given the lengthy amortization schedules — 10 years for working capital and equipment and as long as 25 years for real estate — the difference won’t be great.

If SBA loans were in the range of 5% to 6% last fall, now business owners are looking at 7.5% to low 8%, and that is for loans that are typically 50 basis points to 75 basis points higher than bank loans.

“The bigger advantages are having longer amortizations, a longer time to pay back the loan, so it doesn’t influence cash flow as much month to month, and less covenants,” Hurn said.

The increased interest in SBA loans should last for a while, but Arora said that another 250 basis points in Fed rate hikes and that overall demand will start to dampen. The latest Wall Street forecasts anticipate two more hikes from the Fed this year after Wednesday, with a potential total hike of 75 basis points more across multiple FOMC meetings — 50 in September and 25 later in the year. That’s 150 basis points including Wednesday’s FOMC decision, and when factoring in the 150 points of tightening made earlier in 2022, a total of 300 basis points in higher lending costs.

In taking the benchmark overnight borrowing rate up to a range of 2.25%-2.5% on Wednesday, the consecutive 75 basis point hikes in June and July represent the most aggressive moves since the Fed began using the overnight funds rate as the principal tool of monetary policy in the early 1990s, and took rates back up to where they last peaked in 2019.

4. Women and minority-owned businesses suffer the most

When banks tighten, minority and women-owned small businesses suffer in a disproportionate manner.

Aside longstanding institutional barriers to accessing capital, some of the reasons come down to a business profile among these owners which leads banks to be tougher on them. According to Arora, women and minority-owned businesses tend to be smaller, have less cash flow and less history of servicing debt, and lower margins, which at a time of greater economic pressure makes margins even more vulnerable. They also tend to be concentrated in more sensitive sectors of the economy, smaller retail operations, for example, rather than health care or IT companies. Banks, therefore, are more likely to lend to more established firms able to meet higher debt service coverage ratios.

“That happens in every recession and they have to borrow more expensive debt to stay afloat,” Arora said. 

On the plus side, debt already granted through the PPP and EIDL programs has helped to lower the overall debt needs compared to what they would traditionally be at this point in the economic cycle. And their ability to manage cash flow during the pandemic and make payments means they are coming into the slowdown in a better position to access debt, at least compared to history.

5. Rates should not be the No. 1 determinant of business debt decisions

The mortgage market has been the primary example of how quickly sentiment can shift, even when rates remain low relative to history, with homebuyer demand declining rapidly as mortgage rates have gone up. For business owners, the decision should be different and not based solely on the interest rate.

Business owners need to make a calculated decision on whether to take on debt, and that should be based on analysis of the opportunity to grow. Higher cost debt, and a slight drag on margins, is a price that a business should be willing to pay if top line growth is there for the long-term.

Arora says the most likely determinant right now is what happens with consumer demand and the macroeconomy. The lack of visibility in 2008 led many business owners to pull back on debt. Now, an 8% to 9% interest rate on a loan isn’t as big a factor as whether their sales outlook is improving, their average bill going up or down, and their ability to find workers improving or worsening.

“They shouldn’t mind taking the hit on the bottom line if they can see where it’s going, helping to gain more new clients and pay bills, and stock up on inventory ahead of the holidays,” Arora said.

The recent slowdown in commodities inflation, led by gas prices, should help buoy consumer demand and, in turn, improve cash flow for business owners. But Arora said the next major trend in business loan activity will depend on whether demand stays strong. The majority of small business owners expect a recession to start this year, and will be looking for signs of confirmation.

The Fed said in its statement on Wednesday that while recent indicators of spending and production have softened, the job market remains strong and unemployment low. Fed Chair Jerome Powell said in his press conference that he does not think the economy is in a recession, but that as the central bank continues to tighten, it would at some point “become appropriate to slow the pace of increases while we assess how our cumulative policy adjustments are affecting the economy and inflation.”

“Big demand destruction into the holiday season and then they won’t be borrowing,” Arora said. “What they [small businesses] cannot live with is very steep demand destruction.”

Small business job growth remains strong, although slightly slower, says Paychex CEO

Apple CEO Tim Cook dinner, Jony Ive, Laurene Powell Jobs within the panel dialogue

Apple CEO Tim Cook speaks onstage during day two of Vox Media’s Code Conference 2022 in Beverly Hills, California.

Jerod Harris | Getty Images Entertainment | Getty Images

Apple CEO Tim Cook said Wednesday that Apple isn’t putting much effort into improving the texting experience between iPhones and Android devices because its users haven’t asked for it.

“I don’t hear our users asking that we’re putting a lot of energy into this on this front,” Cook said in response to an audience question at Vox Media’s Code conference in Beverly Hills, California. “I would like to convert you to iPhone.”

The answer comes less than a month after Google launched an advertising campaign aimed at putting pressure on Apple.

Currently, texts between iPhones use iMessage, which offers a much smoother experience than when an Android device sends a text message to an iPhone, where text messages appear as green bubbles. Google wants Apple to introduce RCS, a type of messaging intended as a next-generation SMS replacement with encryption and other modern features.

The questioner squeezed Cook and said he couldn’t send videos to his mother because of texting restrictions.

“Get your mom an iPhone,” Cook said.

Privacy Push goes back to Steve Jobs

Cook was joined by former Apple chief designer Jony Ive and Laurene Powell Jobs to discuss the Apple founder’s legacy and announce a new Steve Jobs archive and possible documentary.

Apple’s recent privacy push isn’t a new goal for the company — the thinking actually goes back to founder Steve Jobs, Cook said.

“Steve really embraced the importance of privacy in business in the early days and has only grown since then,” Cook said.

Cook quoted a 2010 paper by Jobs as saying that privacy means that users consent to the sharing of their data. “Privacy means people know what they are signing up for, in plain English and repeated. That’s what it means,” Jobs said in the talk, cited by Cook.

Cook’s comments come as the company’s privacy push has been increasingly criticized as self-serving as the company rolled out new privacy features that make measuring online advertising more difficult as Apple reportedly plans to grow its advertising business and introduce new ad units.

That’s the same philosophy behind App Tracking Transparency, a feature launched in 2021 that rocked the online advertising industry. iPhone owners are asked before providing apps with a unique device identification number at startup – and most iPhone owners choose not to, preventing online advertisers from accurately tracking the performance of their ads.

Companies like Facebook parent Meta have branded the change anti-competitive. In February, Meta said it would cost $10 billion this year.

“We felt that people should own their data and make their own decisions,” Cook said Wednesday. “People should be empowered to make that decision in a really simple and straightforward way. Not buried somewhere 95 pages deep in a privacy policy.”

Cook argued that Apple follows stricter rules than advertisers and defended the company’s search ads.

“We never said digital advertising was a bad thing,” Cook said. “What’s not good is siphoning people’s data if they’re not doing it on an informed basis.”

Cook was asked if he sees Apple as a powerful company that has stepped in because regulators have failed to pass privacy laws.

“We’re not trying to be a regulator,” Cook said. “All we’re trying to do is give people the opportunity to make the decision for themselves.”

The US monkeypox outbreak is slowing as vaccines turn into extra accessible, well being officers say

The monkeypox outbreak in the US is slowing as vaccines become more available and there is broader public awareness of what steps individuals can take to lower their risk of infection, White House health officials said.

Demetre Daskalakis, deputy chief of the White House monkeypox response team, said it took 25 days for cases to double in August, compared with eight days in July. California, New York, Illinois and Texas have all seen significant declines in new cases over the past month, Daskalakis said.

“The positive trends we’re seeing in this data also speak to the actions taken by individuals across the country to protect themselves against the virus, including changing their behavior and seeking testing and vaccines,” Daskalakis said.

The US is still battling the world’s largest monkeypox outbreak, with nearly 21,000 cases reported in all 50 states, Washington DC and Puerto Rico, according to the Centers for Disease Control and Prevention.

Monkeypox is primarily spread through sex among gay and bisexual men, although anyone can catch the virus through close physical contact with an infected person or through contaminated materials such as towels and bed sheets. The disease is rarely fatal but causes painful lesions that resemble pimples or blisters.

The Biden administration was criticized over the summer for not moving quickly enough to increase vaccine supplies to meet the huge demand for the shots. Health Secretary Xavier Becerra declared a public health emergency last month, and the Food and Drug Administration approved a different method of administering the vaccines, allowing providers to extract more doses from each vaccine vial.

Jynneos vaccine, manufactured by Danish biotech company Bavarian Nordic, is the only approved monkeypox vaccine in the United States. It is given in two doses 28 days apart, with the peak immune response occurring two weeks after the second dose.

The CDC does not yet have any real-world efficacy data on the Jynneos vaccine, although public health officials expect it to offer protection against monkeypox.

The supply of vaccines has expanded significantly since the beginning of August. The US has administered more than 460,000 doses of the monkeypox vaccine to date, according to 35-state data provided to the CDC. About 1.6 million gay and bisexual men are at highest risk from monkeypox and have been the focus of vaccination efforts.

Black and Hispanic communities have been particularly hard hit by the virus. According to CDC data, nearly 38% of patients are Black, 29% Hispanic, and 27% White. The total population of the United States is 12% Black, 19% Hispanic, and 61% White, according to the 2020 Census data.

Daskalakis said the CDC and the White House have been working with organizations in black and brown communities to increase vaccine access. Vaccinations were offered on-site at Atlanta Black Pride over Labor Day weekend, with 4,000 doses administered, according to Robert Fenton, head of the White House monkeypox response team.

The US offers on-site immunizations at Pride and other high-attendance events for gay and bisexual men to make immunizations more readily available. More than 3,000 doses were administered at Southern Decadence in New Orleans, according to Fenton. The US is providing 820 cans for Boise Pride and 10,000 cans for California ahead of the Folsom Street Fair and Castro Street Fair, Fenton said.

Daskalakis said federal health officials are also working with colleges and universities when the school comes back into session to brief them on the resources and tools available to deal with monkeypox should there be any infection on campus, although the risk is low .

“The risk at universities is extremely low,” said Daskalakis. “Given the way this virus spreads in the population, the risk in these settings is realistically low. Awareness is more important than fear,” he said.

People with monkeypox should stay home until the rash has healed and a new layer of skin has formed, stay away from other people, and not share objects or materials with other people, according to CDC guidelines.

People with a new or unexplained rash should avoid sex and social gatherings, especially those involving close skin contact, according to the CDC. People can also reduce their risk of infection by temporarily limiting their sex partners until two weeks after receiving the second dose of the monkeypox vaccine.

Ricky Martin Recordsdata $20M Lawsuit Towards His Nephew Following Allegations of Sexual Abuse (Replace)

Ricky Martin has filed a $20 million lawsuit against his own nephew who accused him of sexual abuse and molestation in July.

Back in July, Latin Star Rick Martin was faced with sexual abuse allegations by his own nephew after it was claimed the two had had a sexual relationship. In the end, Ricky won his nephew’s case after the restraining order he had applied for was withdrawn. Now Ricky has filed a $20 million lawsuit against his nephew following the allegations.

According to documents obtained by TMZ, Ricky filed the lawsuit against his nephew Dennis Yadiel Sanchez Martin in San Juan on Wednesday after he said his nephew was trying to “assassinate” his reputation. Ricky claims that after the restraining order was lifted, Dennis began texting him on Instagram threatening to “murder his reputation and integrity” if he didn’t hand over some money.

Ricky claims Dennis bragged about being his nephew before the restraining order and he flooded him with multiple messages for four months. Ricky claims it was obvious the messages came from a “maladjusted person.” Things reportedly continued to deteriorate as Ricky claims Dennis posted his phone number on social media and even created an Instagram account for one of his children.

Ricky says he lost a lot due to Dennis’ false accusations and now he wants at least $20 million to make up for what he lost. He further shared that Dennis made him and his family feel “unsafe” in Puerto Rico and is asking a judge to explain that Dennis refuses to contact him and his family.

As previously reported, Dennis dropped the charges against Ricky in July after accusing him of sexual abuse and harassment and withdrew the restraining order he had placed against the singer.

TSR STAFF: Jade Ashley @Jade_Ashley94

dr Ounceshas ties to hydroxychloroquine firms as he helps Covid remedy

Republican Senate candidate from Pennsylvania, Dr. Mehmet Oz, has financial ties to at least two pharmaceutical companies that supply hydroxychloroquine, an antimalarial drug he circulated as a possible treatment for Covid-19.

Oz, a physician and veteran television host who is up against Democrat John Fetterman in the race for the Pennsylvania Senate seat, owns with his wife at least $615,000 in Thermo Fisher Scientific stock, according to its financial disclosure. Thermo Fisher Scientific’s website lists hydroxychloroquine sulfate as one of the available products. It’s unclear when Oz and his wife bought the stock or if they owned it, as Oz promoted hydroxychloroquine as a Covid treatment early in the pandemic.

Oz and his wife also own between $15,001 and $50,000 in McKesson Corporation stock, according to the disclosure. According to the FDA, the company labels and sells hydroxychloroquine sulfate. It’s also unclear when they bought McKesson stock.

Hydroxychloroquine sulfate is the anti-malarial drug commonly known as hydroxychloroquine, according to the Food and Drug Administration. Doctors across the country, helped in part by support from former President Donald Trump and conservative media figures, have been offering the drug to patients as a Covid treatment, despite its questionable effectiveness against the virus.

Oz’s financial ties to a manufacturer and distributor of the drug, and his promotion of it as a potential Covid treatment, raise questions about what he would benefit from its wider use during the pandemic. If he wins the Senate election, he could also face conflicts of interest as Congress grapples with a still-evolving coronavirus pandemic.

In a statement responding to CNBC questions about Oz’s ties with companies that manufacture or distribute hydroxychloroquine, including when he and his wife bought shares in Thermo Fisher Scientific, Oz campaign spokeswoman Brittany Yanick, does not affect the financial interests of the candidate.

“At the beginning of the pandemic, Dr. Mehmet Oz with healthcare professionals worldwide who are considering hydroxychloroquine and azithromycin as viable treatment options for critically ill COVID patients. He offered to fund the clinical trial at Columbia University,” she said.

The FDA has approved hydroxychloroquine to fight malaria but warned that it “has not been shown to be safe or effective for treating or preventing COVID-19.”

Oz took bold steps early in the pandemic to promote its use as a treatment. He urged Trump administration officials in 2020 to support a study he wanted to fund at Columbia University Medical Center on the effect of hydroxychloroquine on Covid-19 patients, according to emails obtained by the select subcommittee of the House of Representatives on the coronavirus crisis have been received and published.

Oz also has ties to a third company, which it says has divested hydroxychloroquine from its US portfolio.

Sanofi, which is headquartered in France and previously manufactured hydroxychloroquine, supported Oz’s nonprofit HealthCorps for years, according to the group’s annual disclosure reports. Between 2009 and 2018, Sanofi was listed as either a sponsor or donor in kind to the Oz-funded group, which owns aims to help teenagers with their health and well-being. In 2013, Sanofi is listed as one of the group’s “School Sponsors”. HealthCorps’ website states that a school sponsor must donate $100,000 to qualify.

Sanofi announced in April 2020 that it would donate 100 million doses of hydroxychloroquine to 50 countries around the world as studies evaluated the drug’s effectiveness in treating Covid-19.

A spokesman for Sanofi told CNBC that the company was not involved in Oz’s comments about Covid-19 or hydroxychloroquine. He explained that Sanofi divested hydroxychloroquine from its US portfolio in 2013 and was investigating the drug’s use as a potential way to fight the virus early in the Covid pandemic. After it was deemed ineffective against Covid-19, the company’s work on it was suspended.

The spokesperson also explained that the company’s last financial contribution to HealthCorps was in 2011. The company representative later corrected himself in a follow-up email to CNBC after the publication of this story, saying that 2013 was actually the last year that Sanofi made a financial donation to HealthCorps.

Oz’s ties to companies that would benefit from wider use of hydroxychloroquine could pose problems for the Republican if he wins the Senate seat. Kedric Payne, an ethics attorney at the Campaign Legal Center, told CNBC in an email that Oz could choose to walk away from the companies if he defeated Fetterman in November.

“He could have a rude awakening if elected because ethics rules could bar him from the job. Senators cannot use their positions to promote goods or services that benefit them financially,” Payne said. “Oz could voluntarily divest the shares if elected or stop promoting anything tied to his shares.”

A spokesman for Thermo Fisher Scientific declined to comment. A McKesson representative did not respond to a request for comment prior to publication.

Since launching his campaign late last year, Oz has downplayed warnings from the FDA and other experts against the use of hydroxychloroquine as a Covid treatment. He suggested political animus against Trump endorsing the drug as a treatment and Oz in the Senate election, motivating criticism of the drug as a way to combat Covid.

“Well let me say this real quick, I really don’t know if it works or not, we haven’t been able to prove to this day if it works [hydroxychloroquine] works or not, which is a shame because we should have known by now whether a cheap 70-year-old drug used by a billion people works or not,” Oz said at a campaign event earlier this year. “But we don’t know. t which is a problem in itself. However, I mentioned it and then President Trump mentioned it in a press conference and suddenly the whole world hated hydroxychloroquine without testing it, without knowing it.”

Before launching his campaign, Oz championed hydroxychloroquine more explicitly. During an interview with Fox News in March 2020 at the height of the pandemic, Oz said that “hydroxychloroquine has a role” in fighting the virus. An on-screen graphic while Oz was being interviewed called the anti-malarial drug “promising” as a treatment option for Covid-19.

Oz also sought White House help to get the hydroxychloroquine trial going, which he wanted to fund at Columbia, where he was once vice chairman of the department of surgery. He has since said the study never got off the ground.

The Pennsylvania nominee’s communications with White House officials were released last month by the House’s select subcommittee on the coronavirus crisis. In an email dated March 2020 Deborah Birx, former Trump White House coronavirus response coordinator, told Oz he would recruit patients and pay for the hydroxychloroquine trial himself.

Also in March 2020, Oz Trump’s son-in-law and adviser Jared Kushner emailed that “we must make the completion of this study a national priority and insist on immediate enrollment,” according to correspondence obtained by the House Committee and has published. Kushner replied to Oz the same day, “What do you recommend to speed it up?”

The New York Post reports that Oz spent $8,800 on hydroxychloroquine tablets for the study at the time and offered to spend $250,000.

Oz, during his campaign for the Pennsylvania Senate seat, accused then-New York Governor Andrew Cuomo of stopping the study after effectively banning the anti-malarial drug as a Covid treatment.

Oz’s financial ties could pose a bigger problem for him if he wins the Pennsylvania race, one of a few contests to decide which party will control the Senate next year. A Real Clear Politics poll average shows Fetterman leading Oz by almost 7 percentage points.

Share ownership in Congress will come under increased scrutiny. Some lawmakers in Congress have proposed a ban on individual stock deals that would require lawmakers to invest assets in a blind trust or to divest them outright.

Business Insider has identified at least 71 lawmakers who have violated the Stop Trading on Congressional Knowledge Act, or STOCK Act. The law aims to prevent members of Congress from trading stocks using inside information gained from their work as legislators.

By and large, however, members of Congress had little impact on lucrative stock deals.

Andy Jassy says he will not pressure Amazon workers to return to the workplace

Andy Jassy, ​​Chief Executive Officer of Amazon.Com Inc., during the GeekWire Summit in Seattle, Washington, U.S. on Tuesday, October 5, 2021.

David Ryder | Bloomberg | Getty Images

Amazon CEO Andy Jassy said the company has no plans to order company employees to return to the office.

“We have no plan to ask people to come back,” Jassy said on stage at the Code conference in Los Angeles on Wednesday. “We’re not doing that at the moment. But we’ll be adaptive as we learn.”

Amazon tech workers were ordered to work from home in early 2020 as the coronavirus spread rapidly. In October, Jassy said Amazon would let individual managers decide how often employees need to come into the office, a sharp departure from its earlier goal of returning to an “office-centric culture.”

Jassy said most employees returned to physical offices on Wednesday and are working from home for a few days. Certain teams tend to be in the office more often, such as hardware or creative departments, while others, such as engineers, continue to work largely remotely, he added.

“I think there are some things that are more difficult to do remotely,” Jassy said. “I think it’s a little harder to invent from afar.”

Jassy has previously said the Covid-19 pandemic could have a lasting impact on how offices are used and noted that it has already impacted hiring at Amazon. For example, Amazon is now more open to remote work and will recruit employees from any location rather than just focusing on areas where it has “critical mass,” he said.

Amazon’s position on remote work differs from that of some of its tech peers. Google in April began requiring most employees to return to physical offices at least three days a week, prompting some backlash from workers who defy the mandate. Apple also asked some of its employees to come into the office three days a week starting this month.

CLOCK: Watch CNBC’s full interview with Amazon CEO Andy Jassy

UiPath, ChargePoint, Twitter and extra

The logo and commerce icon for Twitter is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City on July 11, 2022.

Brendan McDermid | Reuters

Check out the companies making headlines in midday trading.

UiPath — Shares plummeted 12.9% after UiPath released weaker-than-expected third-quarter and full-year revenue guidance. Still, the robotic process automation software company beat earnings and revenue expectations in the most recent quarter.

Coupa Software — Coupa Software rose 13% after it reported better-than-expected earnings in its most recent quarter and outlined strong earnings and revenue guidance for the full year.

ChargePoint – ChargePoint rose 8.2% after Credit Suisse initiated coverage of the electric vehicle charging operator with a buy rating, and said shares could climb about 50% from here. The company’s analyst said ChargePoint stations should get a boost from favorable US regulatory policies.

Gitlab — Shares rose 6.7% after the software developer reported a smaller-than-expected loss last quarter. Gitlab also issued better-than-expected guidance for the third quarter.

Pinterest — The social media stock rose 4.6% after Wolfe Research upgraded it to outperform. The company was positive about Pinterest’s new CEO, who analysts say could improve the company’s execution of its long-term user and monetization goals.

Twitter – Twitter shares rose 4.8% after a Delaware court granted Elon Musk’s request to postpone a lawsuit focused on his move to abandon a $44 billion deal to buy the social media company , had set. However, the court said it would allow Musk to add claims from a Twitter whistleblower to his counterclaim.

Starbucks – Shares of the coffee chain rose 3% after Barclays said there were buying opportunities for the stock ahead of Investor Day. Barclays said in a note to customers that they are confident that new Starbucks CEO Laxman Narasimhan will come.

Petco Health and Wellness – Shares of the pet products retailer rose 4.5% after RBC opened coverage with an outperform rating. Noting that much of the flagging consumer environment is already reflected in the stock price, analysts believe Petco is well positioned to acquire stakes in the U.S. pet category “given its revised corporate strategy, structurally advantageous real estate portfolio, and opportunity for expansion.”

Baker Hughes – Energy stocks fell as oil prices fell to a seven-month low, with Brent crude futures and US West Texas Intermediate crude each down more than $3. Baker Hughes shares fell 3.2%. Halliburton was down 2.5% and Occidental Petroleum and Marathon Oil both fell 2.1%.

– CNBC’s Jesse Pound, Samantha Subin and Michelle Fox Theobald contributed coverage.

Bling Empire Season three formally has a premiere date

Bling Empire is back – and the empire is expanding.

Netflix has announced a September 7 release date for the richest reality series. So when can fans expect more drama? Well, the show’s third season will premiere on October 5th.

The show will pick up right where we left off at the end of season two, the streamer teases the resident matriarch Anna Schay “received a shocking visit from someone from the past”. Eagle-eyed viewers will recall that this is indeed a mysterious character Andrew Graythe ex-boyfriend of Kelly Mi Li, whom we first met in the first season. After being on and off on and off for over five years, the couple split in March 2021.

Season 3 will also focus on many of our other favorite blingers, including Kane Lim, who “books a big fashion campaign and surprisingly starts a whole new career,” according to the streamer. On the other hand, Netflix reveals that his quarreling best friend, Kevin chalk, revives “an old romance”. Seems like he’s moved on Kim Lee.

And of course the eternal proxy war between Anna and Christine chiu rages.

New York ends masks necessities on subways, buses and different public transport

A Metropolitan Transportation Authority (MTA) logo is displayed on the side of a subway train in Manhattan, New York, June 2, 2021.

Ed Jones | AFP | Getty Images

New Yorkers will no longer be required to wear masks on subways, buses and other mass transit, Gov. Kathy Hochul announced Wednesday.

Hochul said the decision to end the mandate takes effect immediately. The governor said New York is in a much stronger place as infections and hospitalizations fall. New boosters targeting the dominant Omicron subvariant BA.5. should also provide better protection against Covid, she said.

“We think we’re in a good place right now, especially if the New Yorkers take that boost. So we’re not just returning to a new normal, but a normal normal, and that’s what we’re striving for,” Hochul said during a news conference.

New York introduced mask requirements on public transport more than two years ago, when the city was the US epicenter of Covid. Many New Yorkers began ignoring the mandatory in the spring after near-universal compliance at the start of the pandemic.

Masks are still required in nursing homes and hospitals, Hochul said.

New York State Health Commissioner Dr. Mary Bassett said the Omicron boosters should offer better protection against infection because the vaccinations are now consistent with the dominant variant, although there is no data on the effectiveness of the vaccinations yet.

“If it has been more than two months since you had your last vaccination, you are 12 years of age or older you should get a booster and this time it may be a booster which we think people will get a lot out of offers more protection,” Bassett said.

CNBC Health & Science

Read CNBC’s latest global health coverage: